Cell lines: WT and PACS-2 -/-primary MEFs were isolated from E13.5 embryos and were propagated or immortalized by infection with a retrovirus expressing SV40 large T antigen (provided by R. Cone, OHSU). TAg-PACS-2 -/-cells rescued for PACS-2 expression (TAg-PACS-2 R ) were generated by stable transfection with pcDNA3.1-PACS-2-HA or empty vector (TAg-PACS-2 V ) and pCEP4 to confer hygromycin resistance. MEFs were grown in DMEM supplemented with 10% fetal bovine serum. WT and Akt1 -/-MEFs (from N. Hay, UIC), A7, BSC-40, HEK293, HeLa and MCF-7:Bid-GFP cells were cultured in DMEM supplemented with 10% fetal bovine serum. HCT-116 cells (from B. Vogelstein) were cultured in McCoy's 5A supplemented with 10% fetal bovine serum and DLD-1 cells were cultured in RPMI 1640 supplemented with 10% fetal bovine serum.
Human Tissues: 200 mg portions of resected, staged colorectal cancer specimens with adjacent normal colonic tissue controls were isolated from consenting patients under approval from the OHSU and KP IRB. Tissue samples were quick-frozen in liquid nitrogen and homogenized in mRIPA (50 mM Tris pH 8.0, 1% NP-40, 1% sodium deoxycholate and 150 mM NaCl) supplemented with complete protease and phosphatase inhibitors. Extracts were centrifuged at 15,000 xg (30 min, 4 o C) and analyzed for PACS-2 protein by western blot.
Fluorescence polarization.
FP assays for 14-3-3 interactions were performed as previously described (Du et al., 2006) . TMRhodamine-conjugated peptides for Ser 244 -PACS-2 (TMR-RRSIVRTTSMTRQQN), pSer 244 -PACS-2 (TMR-RRSIVRTTpSMTRQQN), Ser 437 -PACS-2 (TMR-GRRGRSTSLKERQA) and pSer 437 -PACS-2 (TMR-GRRGRSTpSLKERQA) were from Anaspec. The fluorescence polarization (FP) signals were recorded after 1 hr of incubation using the Analyst HT. The assay window was defined by subtracting free peptide polarization values from values of bound peptide recorded in the presence of specified protein concentrations of GST-14-3-3. The data were fit to the model FP = ([14-3-3] • Bmax)/([14-3-3] + K d ) using nonlinear regression analysis, where B max is the maximal binding (Prism 4.0; Graphpad).
Mass Spectrometry.
PACS-2-HA immunoisolated from BSC40 cells was subject to partial in-gel trypsin digestion as described (Shevchenko et al., 2006) . Phosphopeptides were enriched as described (Larsen et al., 2005) , dissolved in formic acid, desalted on a POROS Oligo R3 reversed-phase column (ABI), and eluted into a nanoelectrospray needle with either ammonium hydroxide/acetonitrile for precursor ion scanning in negative ion mode or acetic acid/acetonitrile for tandem mass spectrometry (MS/MS) in positive ion mode. Precursor ion mass spectrometry analysis was performed on a QSTAR XL quadrupole time-of-flight mass spectrometer equipped with a nanoelectrospray ion source (MDS Proteomics). After identification of candidate phosphopeptides, the remaining sample was used to identify sites of phosphorylation by nanoscale LC-MS/MS sequencing on an LC-Packings (Dionex) nanoLC system coupled to a Thermo LCQ Deca XP MAX quadruple ion trap mass spectrometry system.
Supplemental References
Larsen, M. R., Thingholm, T. E., Jensen, O. N., Roepstorff, P., and Jorgensen, T. J. Comparison of the tandem mass spectra from an in vivo PACS-2 phosphopeptide and a synthetic peptide of the determined sequence. Top; PACS-2 tryptic peptide spectrum as described in Fig. 4d . Bottom, fragmentation spectrum of synthetic RST(pS)LKER.
Figure S3. Mapping phosphorylation on PACS-2 Ser 349 .
Peptides from in-gel trypsin digestion of PACS-2 immunoisolated from BSC-40 cells were enriched for phosphopeptides on TiO 2 , desalted on a POROS R3 microcolumn and evaluated for phosphopeptides by nanoLC-MS/MS on a Thermo LCQ Deca XP quadrupole ion trap mass spectrometer all as described for Fig. 4d . A tryptic peptide mass corresponding to phosphorylated EPPSPADVPEK was fragmented to produce diagnostic b-and y-ions to confirm Ser 349 as a site for phosphorylation. Figure S4 . Mapping phosphorylation on PACS-2 Ser 390 . Peptides from in-gel trypsin digestion of PACS-2 immunoisolated from BSC-40 cells were desalted on a POROS R3 microcolumn and evaluated for phosphopeptides by mass spectrometry on an Applied Biosystem 4800 MALDI-TOF/TOF system operated in reflector positive mode for MS analysis and 2kV positive MS/MS mode for peptide sequencing analysis. Top: Fragmentation pattern of the nonphosphorylated tryptic peptide EHPGPEDSPEAEASTLDVFTER with a near compete set of y ions confirming the sequence. Bottom: Fragmentation pattern for the phosphorylated peptide. The y-ion series for the phosphorylated peptide is identical to the non-phosphorylated peptide through y14. However, the phosphorylation of Ser 390 is confirmed by the shift in the y15 ion (by 80 Da, the mass of the phosphate addition to the serine) in the phosphorylated peptide (lower panel). Arrows on both panels indicate the mass differences between y14 and y15 at 87 Da (the residue mass of serine) and 167 Da (the mass of a phosphorylated serine) in the upper and lower panels respectively. One μg of GST-PACS-2 MR or GST was mixed on ice with 1 ng Akt1 (Cell Signaling, #7535), 2 ng Akt2 (Cell Signaling, #7503), 1 ng p70S6K (Cell Signaling, #7684), or 1 ng RSK1 (Cell Signaling, #7398) in kinase buffer (20 mM MOPS, pH 7.2, 25 mM β-glycerophosphate, 5 mM EGTA, 1 mM sodium orthovanadate and 1 mM DTT). Kinase reactions were initiated by the addition of 100 μM ATP and 15 mM MgCl 2 and then incubated at 30°C for 30 min. Reactions were stopped with SDS sample buffer and then processed for western blot using mAb 81. Top: western blot. Bottom: Ponceau S stain of protein input.
